Profacgen, a global supplier of life science research tools, recently announced the launch of its Computer-aided Drug Design Services based on the most state-of-the-art VS techniques and software tools for hit and lead identification.
Rapid developments in the fields of combinatorial chemistry and high-throughput screening (HTS) technologies have enabled large libraries of compounds to be synthesized and screened. While, in general, synthesizing a large number of compounds is quite expensive and time-consuming. Thus, computational methods are gaining increasing popularity in drug discovery.
Now, both ligand-based virtual screening (LBVS) and structure-based virtual screening (SBVS) services are available in Profacgen for customers to choose. According to its official speaker, the computer-aided drug design services in Profacgen enable researchers to effectively screen drug design space and identify most promising candidates. The optimized protocol can reduce the size of chemical library to be screened experimentally, increasing the likelihood to find innovative hits in a faster and less expensive manner, and mitigating the risk of failure in the lead optimization process due to absorption, distribution, metabolism, excretion and toxicity deficiencies.
“By providing researchers with highly optimized computer-aided drug design services, we are enabling scale up to faster drug discovery, and helping reduce the cost at the same time.” commented Crystal, the chief marketing staff in Profacgen.
To know more information about the newly launched computer-aided drug design service in Profacgen, please visit https://www.profacgen.com/computer-aided-drug-design.htm.
About Profacgen
Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development. We also save our clients a great deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.
Media Contact
Company Name: Profacgen
Contact Person: Ellen Burns
Email: info@profacgen.com
Phone: 1-631-448-8149
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: www.profacgen.com/computer-aided-drug-design.htm